Dr. Daws is an Associate Professor at the University of Texas Health Science Center at San Antonio, and studies the function and regulation of biogenic amine transporters, including the serotonin transporter.  She is an expert in the area of in vivo assessments of biogenic amine transporter activity using carbon fibre amperometry and will provide collaborative support for Conte activities to complement studies provided for microdialysis in the Bioanalytical Core.

Dr. Ramamoorthy is an Associate Professor in the Department of Neuroscience at the Medical University of South Carolina.  He studies the contribution of neurotransmitter transporters to central nervous system function, and more specifically, the study of neurotransporter regulation with respect to mental illness, drug abuse, aging and neurodegenerative diseases.  He will serve as a formal consultant on the Blakely project to advise on aspects of SERT phosphorylation in native preparations derived from transgenic mouse strains distinguished by SERT and integrin mutations, as well as after inducible deletion of PKG1 in raphe neurons.

Dr. Lucki is a Professor in the Departments of Psychiatry and Pharmacology in the School of Medicine at the University of Pennsylvania.  His studies focus on the role of neurotransmitters, such as serotonin, in the behavioral effects of antidepressant and anxiolytic drugs using rodent animal models.  He will provide consultation services to the Biobehavioral Core, providing advice on experimental protocols related to depression and SSRI responsivity.